### ðŸ«  Pericardial Disease: Asymptomatic Idiopathic Pericardial Effusion Management

#### âœ… True Statements
1. Many **pericardial effusions** are asymptomatic and discovered incidentally on **chest radiography, computed tomography (CT), or transthoracic echocardiography (TTE)**.
2. In asymptomatic patients, most pericardial effusions are **idiopathic**, but potential causes such as **malignancy, infection (including tuberculosis), autoimmune disease, hypothyroidism, and iatrogenic factors (for example, anticoagulation therapy)** must be considered.
3. In countries where **tuberculosis** is endemic, **more than 60%** of pericardial effusions are attributable to **tuberculosis**.
4. Asymptomatic patients with a **small to moderate-sized idiopathic pericardial effusion** and **no clinical or echocardiographic evidence of cardiac tamponade** should undergo **surveillance with repeat TTE in 6â€“12â€¯months** rather than immediate intervention.
5. **Pericardiocentesis** is recommended only when **malignancy or bacterial infection is strongly suspected** or when **pericardial tamponade** is present; it is **not routine** for stable, idiopathic small to moderate effusions.
6. **Pericardial window surgery** is **not indicated** for management of a small to moderate-sized asymptomatic idiopathic pericardial effusion.
7. **Right heart catheterization** is reserved for situations in which **cardiac tamponade** is suspected but cannot be confirmed nonâ€‘invasively and is **unnecessary** in uncomplicated asymptomatic effusions.

#### ðŸ’¬ Extra
1. Incidental effusions are frequently detected during imaging performed for pulmonary or oncologic indications.
2. A targeted evaluation typically includes history, physical examination, basic laboratory studies (including thyroid function), and cancer or infectious workâ€‘up guided by risk factors.
3. The high prevalence of tuberculous effusion in endemic areas necessitates focused diagnostic testing for **Mycobacterium tuberculosis**.
4. Enlargement or development of symptoms between imaging studies should prompt earlier reassessment and possible intervention.
5. Diagnostic pericardiocentesis allows fluid cytology and cultures, while therapeutic drainage relieves hemodynamic compromise in tamponade.
6. Surgical pericardial window creation is generally reserved for recurrent, large, or loculated effusions that do not respond to percutaneous drainage.
7. Hemodynamic assessment with catheterization shows equalization of diastolic pressures in tamponade but adds no value when tamponade is not suspected.

#### ðŸ”· Tags
#Cardiology #PericardialDisease #PericardialEffusion #AmbulatoryCare #HighValueCare #Echocardiography #CardiacTamponade #Tuberculosis

#### ðŸ“™ Reference
Adler Y, Charron P, Imazio M, etâ€¯al; ESC Scientific Document Group. **2015â€¯ESC Guidelines for the Diagnosis and Management of Pericardial Diseases**. *European Heart Journal*. 2015;36:2921â€‘2964. PMID:â€¯26320112. doi:10.1093/eurheartj/ehv318

#### ðŸ†” Question ID
CVMCQ24083

#### ðŸ•’ Last Updated
Februaryâ€¯2025

---

#### ðŸ“– Related Text
MKSAPâ€¯19: Cardiovascular Medicineâ€¯â€”â€¯Pericardial Disease, Pericardial Effusion and Cardiac Tamponade

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. In patients with a **pericardial effusion of unknown cause accompanied by elevated inflammatory markers**, empiric treatment for **acute pericarditis** may be considered reasonable.
2. **Large idiopathic pericardial effusions** that persist for **longer than threeâ€¯months** should be evaluated for **drainage**, because approximately **one in three** will progress to **cardiac tamponade**.

#### ðŸ’¬ Extra
1. Empiric therapy typically includes **nonâ€‘steroidal antiâ€‘inflammatory drugs (NSAIDs)** and **colchicine**, aiming to suppress inflammation while further diagnostic studies are pursued.
2. Early drainage of persistent large effusions can prevent hemodynamic compromise and allows fluid analysis to exclude occult malignancy or infection.

#### ðŸ”· Tags
#PericardialEffusion #Pericarditis #CardiacTamponade #InflammatoryMarkers #PericardialDrainage

---

#### ðŸ—¾ Supplemental Tables

<!--Causes of Pericardial Disease-->
<table>
  <caption><strong>Causes of Pericardial Disease</strong></caption>
  <thead>
    <tr><th>Category</th><th>Cause</th></tr>
  </thead>
  <tbody>
    <tr><td colspan="2"><strong>Infectious</strong></td></tr>
    <tr><td>Viral infection</td><td>Enterovirus, herpesvirus, adenovirus, parvovirus</td></tr>
    <tr><td>Bacterial infection</td><td><em>Mycobacterium tuberculosis</em>, <em>Pneumococcus</em> spp., <em>Staphylococcus</em> spp., <em>Coxiella burnetii</em>, <em>Borrelia burgdorferi</em></td></tr>
    <tr><td>Fungal infection</td><td><em>Histoplasma</em>, <em>Aspergillus</em>, <em>Blastomyces</em>, <em>Candida</em> spp.</td></tr>
    <tr><td colspan="2"><strong>Noninfectious</strong></td></tr>
    <tr><td>Autoimmune diseases</td><td>Systemic lupus erythematosus, rheumatoid arthritis, SjÃ¶gren syndrome, systemic sclerosis, sarcoidosis, familial Mediterranean fever</td></tr>
    <tr><td>Cancer</td><td>Metastatic lung cancer, breast cancer, and melanoma; lymphoma and leukemia</td></tr>
    <tr><td>Metabolic conditions</td><td>Uremia, myxedema</td></tr>
    <tr><td>Drug-related causes</td><td>Hydralazine, procainamide, minoxidil, all-trans retinoic acid</td></tr>
    <tr><td>Iatrogenic causes</td><td>Cardiac surgery (postpericardiotomy syndrome), coronary perforation during percutaneous intervention, pacemaker lead penetration, radiofrequency ablation</td></tr>
    <tr><td>Other</td><td>Myocardial infarction (peri-infarct and postâ€“cardiac injury), irradiation, aortic dissection, pulmonary arterial hypertension</td></tr>
  </tbody>
</table>